Professionals 316 results
- Yulia Makarova
- Partner of Winston & Strawn London LLP
- +44 20 7011 8803
- vCard
Partner of Winston & Strawn London LLP
Capabilities 84 results
Practice Area
Financial Innovation & Regulation
Practice Area
Privacy: Regulated Personal Information (RPI)
Industry
Experience 197 results
Experience
|March 25, 2026
Experience
|March 6, 2026
Transition Evergreen & Zencap Agreement: Winston Advises Transition Evergreen on Its Restructuring
Experience
|March 4, 2026
End of the Line: Winston Wins Unanimous Supreme Court Victory Against NJ Transit
Insights & News 4,448 results
Investigations, Enforcement, & Compliance Alerts
|April 8, 2026
|4 Min Read
Court Ruling Curtails Administration’s Ability to Terminate Grants Based on New Priorities
On March 24, 2026, the U.S. District Court for the Northern District of Illinois decided that federal grantees can challenge grant terminations by the Administration if at the time of termination the grantees were compliant with Administration policies that were in place at the time the grant was awarded, as opposed to new rules or policies subsequently imposed by the Trump Administration. This decision could aid federal contractors and grantees in their legal challenges to the numerous contract and grant terminations, which have occurred since January 2025, based on alleged failure of the contracts or grants to align with or effectuate new Administration programs, policies, goals, and/or priorities, including, but not limited to, those relating to diversity, equity and inclusion (DEI) programs and policies.
Press Release
|April 8, 2026
|1 Min Read
Winston Expands Leveraged Finance Team with Partner R. Lee Discher
In the Media
|April 8, 2026
|3 Min Read
Winston Represents Former FirstEnergy Executive in Ohio Bribery Trial
Other Results 111 results
Site Content
What Is the Federal Acquisition Regulation (FAR)?
Law Glossary
What Is the General Data Protection Regulation (GDPR) Law?
Law Glossary
What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?


